Navigation Links
ACC and CRF announce partnership on ACC's Innovation in Intervention: i2 Summit
Date:5/28/2008

(MAY 28, 2008 -- WASHINGTON, DC) The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) announced today a multi-year partnership to jointly sponsor the ACC i2 interventional cardiology meeting in Orlando, Fla., March 2831, 2009, during ACC.09, the ACCs 58th Annual Scientific Session and the worlds premier cardiovascular meeting. This will be the beginning of a five-year partnership committed to collectively developing the interventional component of the ACC Annual Scientific Session.

The ACCs Innovation in Intervention: i2 Summit in partnership with the Cardiovascular Research Foundation in Orlando will deliver in-depth and cutting-edge science provided in a forum for both general cardiologists and interventional specialists, educating and guiding physicians, as well as cardiac care team members, to the next level of knowledge and practice. The meeting will emphasize the translation of evidence-based science and clinical trial data into daily interventional practice.

We are honored to partner with the ACC to organize and enhance the preeminent interventional cardiology meeting of the spring, said Gregg W. Stone, M.D., Chairman of the Cardiovascular Research Foundation and professor of medicine at Columbia University Medical Center/New York-Presbyterian Hospital. The annual scientific session of the American College of Cardiology represents a unique opportunity to introduce the latest advances in interventional medicine to the greater cardiology community. It is our hope that CRFs expertise in cutting edge medical education will help appropriately translate evidence-based science into clinical practice.

The i2 Summit will offer unsurpassed evidence-based content, presented by leaders in interventional cardiology, and this collaboration brings together the strengths and expertise of both the ACC and CRF to deliver an unparalleled program that appeals to all cardiovascular professionals, said ACC President Douglas Weaver, M.D. The ACC is committed to providing more value to attendees at our meeting by having a wide venue of educational opportunities for physicians including state-of-the-art updates, late breaking clinical trials and education required for credentialing and recertification.

The program committee will assemble a broad-based group of domestic and international interventional cardiologists and other heart disease specialists to provide a forum for interventional cardiology experts to discuss new developments within the field as well as a focused venue to train, educate and guide their colleagues in intervention and cardiac care. The program will feature late-breaking clinical trials, case-based education, and analysis of advances in treating diseases of the coronary, vascular, and peripheral vessels as well as pediatric and structural heart disease.

In the coming weeks, additional details about the meeting will be announced.


'/>"/>

Contact: Judy Romero
jromero@crf.org
212-851-9311
Cardiovascular Research Foundation
Source:Eurekalert

Related medicine news :

1. DRAXIS Announces Completion of Sale to Jubilant
2. WellPoint Announces Realignment of Operations, Technology and Government Services Unit
3. Hill-Rom Announces Third Quarter 2008 Dividend
4. VirtualHealth Technologies, Inc. Announces Management Appointment
5. CYNACON / OCuSOFT(R) Announces OCuSOFT(R) Lid Scrub(TM) PLUS Now Available in CVS Pharmacies
6. Innolife Pharma Inc. Announces The Launching Of A New And Improved Website
7. Watson Announces Oxybutynin Topical Gel NDA Accepted for Filing by FDA for the Treatment of Overactive Bladder
8. ABC, CBS, NBC Announce Historic Collaboration to Stand Up To Cancer
9. ABC, CBS, NBC announce historic collaboration to stand up to cancer
10. Collaborative Drug Discovery and Myelin Repair Foundation Announce Partnership
11. Pennsylvania Attorney General Corbett Announces Multi-State Settlement With Express Scripts Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... typically been previously exposed to more adverse experiences than children in the general ... trauma such as abuse, neglect or other family challenges. While no fault of ...
(Date:4/28/2017)... Harbor, Md. (PRWEB) , ... April 28, 2017 ... ... Care Association of America (UCAOA) and College of Urgent Care Medicine will host ... 2017 workshops, sessions and speakers will help those in the industry adapt to ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to accept that hearing ... aid doesn’t have the stigma it had when great-grandpa wore his hearing aids years ... in a NALA North American Speaker Series (NASS) segment. “He probably wore ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The ... which name the Creator responds to and which He does not. Yisrayl says with ... which one is the true name, but he says with a little Scripture, backed with ...
(Date:4/28/2017)... ... April 28, 2017 , ... Phytomer USA is pleased to ... 20+ years of experience within the beauty industry, ranging from marketing, retail support, ... high-end cosmetic brands, retail brands and outlets in Canada and New York. As ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017  Cogentix Medical, Inc. ... on providing the Urology, Uro/Gyn and Gynecology markets ... Ash Keswani has joined the Company as Senior ... newly created position, Mr. Keswani will report directly ... "Our organization is delighted that Ash ...
(Date:4/20/2017)... , April 20, 2017 Research and ... Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing ... their offering. ... for drug delivery technologies will rise from USD 20 Billion in ... Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding ...
(Date:4/20/2017)... -- Eyevensys, a private biotechnology company developing ... technology that enables the safe, local, sustained production of ... range of ophthalmic diseases, announces it has received approval ... (MHRA) to advance its technology into clinical development. ... The EyeCET platform ...
Breaking Medicine Technology: